-
Research Services<a class="dhimg1" href="/shichangdetail1/9.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/8926ff01-64bc-4928-a995-396bdb9d8102.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/8.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/26342b34-4f1e-4d28-9166-7b685e6d70c3.jpg" alt="Aniphe BioLab"> </a>
-
-
Preclinical CRO<a class="dhimg1" href="/shichangdetail/6.html" target="_self" rel="nofollow"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/cc43bac1-07d9-4340-9677-fbe01c51330a.jpg" alt="Aniphe BioLab"> </a> <a class="dhimg2" href="/shichangdetail/10.html" rel="nofollow" target="_self"> <img src="https://omo-oss-image.thefastimg.com/portal-saas/pg2026042316544414203/cms/image/f1d8f739-0d36-4cb8-adeb-26de791d909c.jpg" alt="Aniphe BioLab"> </a>
-
-
-
-
Publish an article
Fracture
Introduction to Animal Models of Fractures
Fracture animal models are classic experimental systems for investigating the mechanisms of bone injury repair and regeneration. By mimicking clinical fracture conditions, they enable dynamic observation of the entire fracture-healing process, including inflammatory responses, cartilaginous callus formation, mineralization of the bony callus, and bone remodeling. In studies of established fracture-healing theories, these models are frequently employed to analyze cellular dynamics, callus formation, and the patterns of ultrastructural changes during healing, while also allowing for systematic evaluation of bone‑tissue repair rates, restoration of bone quality, and alterations in mechanical properties. Characterized by well-defined pathological processes, a comprehensive array of assessment parameters, and excellent reproducibility, these models provide a reliable experimental platform for research into fracture-healing mechanisms, the development of osteo‑regenerative therapeutics, and the evaluation of biomaterials and regenerative‑medicine technologies.
Service Advantages of the Aniphe BioLablogical Fracture Animal Model Platform
Leveraging a well-established bone disease model platform and a standardized experimental system, Aniphe BioLab offers high-quality, one-stop research services for fracture animal models.
![]() |
A wide range of modeling options is available. It supports the establishment of various fracture models, including closed, open, transverse, and defect-type fractures. |
![]() |
The model is stable and reliable. Standardized modeling procedures ensure precise fracture localization, high success rates, and excellent reproducibility. |
![]() |
Multidimensional pharmacological evaluation X-ray, micro-CT, histopathology, bone biomechanics, and bone metabolism assays are available. |
![]() |
Supports personalized design The fracture site, fixation method, and observation period can be customized to meet research requirements. |
![]() |
Standardized Quality Management Comprehensive quality control throughout the entire process ensures that experimental data are authentic, complete, and traceable. |
![]() |
One-stop experimental services It covers the entire workflow, from animal husbandry and model development to pharmacological intervention, sample analysis, and data interpretation. |
|
The filament occlusion method (MCAO) is used to establish the model, which avoids craniotomy, minimizes animal trauma, and yields highly reproducible results. |
Standardized surgical protocols, combined with an experienced technical team, ensure the stability and consistency of model creation. |
The Longa score and the Bederson score, combined with TTC staining, were used to comprehensively validate the model’s phenotype. |
Retain photographs of key procedural milestones and original records to ensure traceability of the experimental process. |
A standardized in vivo solution that meets the needs of cerebral ischemia mechanism research and drug efficacy evaluation. |
| Modeling cycle | 6–8 weeks |
|
|
Mice and rats with SPF diseases |
|
|
Commonly used anabolic agents include teriparatide, sodium alendronate, bone morphogenetic protein‑2 (BMP‑2), and bone‑healing–promoting formulations, among others. |
|
|
It is primarily used for research on fracture‑healing mechanisms, screening of bone‑repair‑promoting drugs and natural bioactive compounds, preclinical evaluation of the efficacy and safety of biologics, cell therapies, bone tissue‑engineering materials, and internal fixation devices, as well as translational studies of technologies related to bone regeneration and repair. |
Construction of an animal model of fracture
01 Surgical Method
The target bone (e.g., femur, tibia, or radius) is exposed via surgery, a standardized osteotomy is performed using a bone saw or osteotome, and the fracture is stabilized with an intramedullary nail, a plate, or an external fixator, thereby establishing a stable fracture model. This method offers precise control over the fracture site and excellent reproducibility, making it well suited for studies on fracture healing and bone regeneration.
02 Closed Fracture Reduction Technique (Bedside Fracture Surgery)
Under anesthesia, the animal’s limb is immobilized on a fracture‑induction apparatus, and a closed fracture is induced by applying a standardized external force; intramedullary nailing may be employed when necessary. This method effectively preserves the periosteal and soft‑tissue structures surrounding the fracture, closely mimicking the natural course of fracture formation, and is commonly used to investigate fracture‑healing mechanisms and to evaluate the efficacy of bone‑repair–promoting agents.
Aniphe BioLab Inc.
Address:
Runcheng, No. 8 Longtai Road, Jiangbei New Area, Nanjing City, Jiangsu Province
Building 8, Science Park
Postal Code: 210007
Phone:025-8520 8061
Email:info@aniphebio.com(Consultation)
Email:order@aniphebio.com(Order)
WeChat Official Account
Video Account


















Positive drug
Application areas
Su Public Security Bureau Internet Information Service Filing No. 32010402001421